Of 582 eyes ( of 486 participants ) with center-involved diabetic macular edema and no preexisting open-angle glaucoma , 260 were randomly assigned to receive a sham injection plus focal/grid laser treatment , and 322 were randomly assigned to receive ranibizumab plus deferred or prompt focal/grid laser treatment .